Clinical trial
A Placebo-Controlled Trial of Memantine for Alcohol Dependence
NCT00246415 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00246415 |
|---|---|
| Title | A Placebo-Controlled Trial of Memantine for Alcohol Dependence |
| Official title | Medications Development for Alcohol Abuse: NMDA Agents -- A Placebo-Controlled Trial of Memantine for Alcohol Dependence |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcohol Dependence (Primary Condition), Alcohol Abuse |
| Intervention type | Drug |
| Interventions | Memantine |
| Enrollment | 90 |
| Start date | Nov 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 31, 2005 |
| Last update posted | Oct 8, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: